AngioDynamics to Participate in 35th Annual J.P. M

ALBANY, N.Y., Jan. 03, 2017 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ: ANGO ), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today that Jim Clemmer, President and Chief Executive Officer and Michael Greiner, Executive Vice President and Chief Financial Officer, are scheduled to present at the 35 ^th annual J.P. Morgan Healthcare Conference on January 10, 2017 at 8:00 p.m EST (5:00 p.m. PST) at the Westin St. Francis in San Francisco.

A live audio and/or webcast and subsequent archived replay of AngioDynamics’ presentation may be accessed via the investor relations section of the Company’s website under “Events & Presentations” at http://investors.angiodynamics.com/events.cfm . The replay will be available for 90 days after the event.

About AngioDynamics AngioDynamics Inc. is a leading provider of innovative, minimally invasive medical devices used by professional healthcare providers for vascular access, surgery, peripheral vascular disease and oncology. AngioDynamics’ diverse product lines include market-leading ablation systems, fluid management systems, vascular access products, angiographic products and accessories, drainage products, thrombolytic products and venous products. More information is available at www.AngioDynamics.com .

Trademarks AngioDynamics and the AngioDynamics logo are trademarks and/or registered trademarks of AngioDynamics Inc., an affiliate or a subsidiary.

Company Contact: AngioDynamics Inc. Caitlin Stefanik (518) 795-1418 cstefanik@angiodynamics.com Investor Relations Contacts: FTI Consulting Jim Polson (312) 553-6730 Jim.Polson@fticonsulting.com, Kotaro Yoshida (212) 850-5690 Kotaro.Yoshida@fticonsulting.com Media Contact: FTI Consulting Kimberly Ha (212) 850-5612 kimberly.ha@fticonsulting.com